Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001104659-24-108134
Filing Date
2024-10-11
Accepted
2024-10-11 18:01:16
Documents
1
Group Members
AARON GLENN LOUIS FLETCHERBIOS ADVISORS GP, LLCBIOS CAPITAL MANAGEMENT, LPBIOS CLINICAL OPPORTUNITY FUND, LPBIOS EQUITY COF, LPBIOS EQUITY PARTNERS II, LPBIOS EQUITY PARTNERS III, LPBIOS EQUITY PARTNERS, LPBIOS FUND II NT, LPBIOS FUND II QP, LPBIOS FUND I

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tm2425783d1_sc13da.htm SC 13D/A 414993
  Complete submission text file 0001104659-24-108134.txt   417447
Mailing Address 1401 FOCH STREET SUITE 140 FORT WORTH TX 76107
Business Address 1401 FOCH STREET SUITE 140 FORT WORTH TX 76107 817-984-5964
BIOS Fund II, LP (Filed by) CIK: 0001714576 (see all company filings)

EIN.: 822436048 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address EMPIRE STATE BUILDING 350 5TH AVENUE, SUITE 5330 NEW YORK NY 10118
Business Address EMPIRE STATE BUILDING 350 5TH AVENUE, SUITE 5330 NEW YORK NY 10118 (646) 600-6438
IN8BIO, INC. (Subject) CIK: 0001740279 (see all company filings)

EIN.: 825462585 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-92777 | Film No.: 241368625
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)